Successful treatment of resistant scleroderma-associated interstitial lung disease with rituximab.
McGonagle
D
D
Tan
A L
AL
Madden
J
J
Rawstron
A C
AC
Rehman
A
A
Emery
P
P
Thomas
S
S
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008875:Middle Aged; D011658:Pulmonary Fibrosis / Q000188:drug therapy*; D000069283:Rituximab; D012595:Scleroderma, Systemic / Q000150:complications*; D014057:Tomography, X-Ray Computed
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D000069283:Rituximab